Feature

The American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline to help primary care clinicians better identify adults who may be at high risk for developing atherosclerotic cardiovascular disease, stroke and who thus may benefit from lifestyle changes or drug therapy to help prevent it.

Home November 15, 2013
Home
News

Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE clinical trial using intravascular ultrasound (IVUS) to study high-risk cardiovascular disease (CVD) patients for assessing benefits of RVX-208.

Home November 15, 2013
Home
News

A study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients with established heart disease.

Home November 15, 2013
Home
Case Study | Tom Coppa

Many healthcare systems are finding their general PACS and cardiology PACS are both aging and their image storage is reaching capacity. How do the diagnostic imaging departments address the needs of their cardiologists and radiologists?

Home November 15, 2013
Home
nanostim pacemaker, SJM
Feature | Dave Fornell, DAIC editor

The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle.

Home November 15, 2013
Home
News

Neovasc Inc. announced that the first patent covering the company's innovative Tiara transcatheter mitral valve replacement technology has been issued by the U.S. Patent and Trademark Office. The new patent protects key aspects of the Tiara mitral valve prosthesis.

Home November 15, 2013
Home
information technology electronic medical records cardiac pacs practice fusion
Feature

As health IT leaders make their way to New York for the New York eHealth Collaborative (NYeC) Digital Health Conference, Practice Fusion, the nation's largest healthcare platform, is looking at the key healthcare trend from 2013 and predicts what they might mean looking forward.

Home November 14, 2013
Home
Feature

Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s (FDA’s) recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

Home November 14, 2013
Home
News

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced detailed preliminary clinical trial results for the world’s first drug-coated scoring balloon catheter.

Home November 14, 2013
Home
Technology

Clear Image Devices LLC (CiD) announced the release of its step platform to be used for standing patient ultrasound venous insufficiency studies. The Ultrasound Exam Steps enable sonographers to place the patient in the optimal position for safe, easy capture of the highest quality venous images of the upper and lower leg.

Home November 14, 2013
Home
News

To help reduce the burden of cardiovascular disease, the nation's leading killer, New York-Presbyterian Hospital and Weill Cornell Medical College have created the Dalio Institute of Cardiovascular Imaging. Raymond T. Dalio, a life trustee of New York-Presbyterian Hospital, has made a gift of $20 million through his Dalio Foundation in support of the institute.

Home November 14, 2013
Home
Feature | Cardiac Imaging

The Eurozone economic slowdown has made it difficult for hospitals, particularly in Southern Europe, to procure new imaging modalities. With streamlined budgets and escalating number of medical procedures, the need to spend less on technologies while gaining the maximum benefit from them has sustained demand for high-quality refurbished imaging equipment.

Home November 14, 2013
Home
cath lab radial access SCAI
Feature

The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries.

Home November 13, 2013
Home
News

InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) trial demonstrating that the MGuard outperformed bare metal and drug-eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients.

Home November 13, 2013
Home
News

Lantheus Medical Imaging, Inc., a developer, manufacturer and distributor of diagnostic imaging agents, announced preliminary results from the first of two planned Phase 3 trials to assess the diagnostic efficacy of flurpiridaz F 18, an imaging agent used in positron emission tomography (PET) myocardial perfusion imaging (MPI) for the detection of coronary artery disease (CAD).

Home November 13, 2013
Home
Subscribe Now